Evidence map›Paper›PMID 20061447›Full record

ArticleMolecular pharmacology2010

Site-specific fluorescence reveals distinct structural changes induced in the human rho 1 GABA receptor by inhibitory neurosteroids.

Ping Li, Alpa Khatri, John Bracamontes, David S Weiss, Joe Henry Steinbach, Gustav Akk

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. UNC-49 is a redox-sensitive GABAScience advances · 2023
    Article
  4. Review
  5. Conformational dynamics and role of the acidic pocket in ASIC pH-dependent gating.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Neurosteroids and GABA-A Receptor Function.Frontiers in endocrinology · 2011
    Article
  11. Mechanism of Allosteric Modulation of the Cys-loop Receptors.Pharmaceuticals (Basel, Switzerland) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ping LiDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Alpa Khatri
John Bracamontes
David S Weiss
Joe Henry Steinbach
Gustav Akk
Washington University in St. Louis · USThe University of Texas Health Science Center at San Antonio · US

Funding

STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUESP01GM047969 · NIGMS · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 1992 to 2011
$18.7M
GABA Channel Activation Domains and MechanismsR01NS035291 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WEISS, DAVID S · 1995 to 2013
$2.7M
GABA Channel Activation Domains and MechanismsR37NS035291 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WEISS, DAVID S · 2003 to 2009
$2.5M
INSECTICIDE ACTIONS ON GABA-A RECEPTORSR03ES016350 · NIEHS · WASHINGTON UNIVERSITY · PI AKK, GUSTAV · 2007 to 2008
$150k
NIEHS NIH HHS ES16350NIEHS NIH HHS R03 ES016350NIGMS NIH HHS GM47969NIGMS NIH HHS P01 GM047969NINDS NIH HHS NS35291NINDS NIH HHS R01 NS035291NINDS NIH HHS R37 NS035291
6 · The paper itself

Abstract

The rho 1 GABA receptor is inhibited by a number of neuroactive steroids. A previous study (J Pharmacol Exp Ther 323:236-247, 2007) focusing on the electrophysiological effects of inhibitory steroids on the rho 1 receptor found that steroid inhibitors could be divided into three major groups based on how mutations to residues in the M2 transmembrane domain modified inhibition. It was proposed that the steroids act through distinct mechanisms. We selected representatives of the three groups (pregnanolone, tetrahydrodeoxycorticosterone, pregnanolone sulfate, allopregnanolone sulfate, and beta-estradiol) and probed how these steroids, as well as the nonsteroidal inhibitor picrotoxinin, modify GABA-elicited fluorescence changes from the Alexa 546 C5 maleimide fluorophore attached to residues in the extracellular region of the receptor. The fluorophore responds with changes in quantum yield to changes in the environment, allowing it to probe for structural changes taking place during channel activation or modulation. The results indicate that the modulators have specific effects on fluorescence changes suggesting that distinct conformational changes accompany inhibition. The findings are consistent with the steroids acting as allosteric inhibitors of the rho 1 GABA receptor and support the hypothesis that divergent mechanisms underlie the action of inhibitory steroids on the rho 1 GABA receptor.

Indexed as

GABA-B Receptor AntagonistsDose-Response Relationship, DrugEstradiolFluorescencegamma-Aminobutyric AcidHumansMutationNeurotransmitter AgentsPicrotoxinProtein ConformationReceptors, GABA-BSesterterpenesEstradiolGABA-B Receptor Antagonistsgamma-Aminobutyric AcidNeurotransmitter AgentsPicrotoxinpicrotoxininReceptors, GABA-BSesterterpenes

Identifiers

PMID20061447
PMCPMC2845946
OpenAlexW2001624620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.